Normalised operating profit before depreciation and amortisation (EBITDA) amounted to 91.9 million euro and is 8.6 million euro higher than in 2022, Podravka said in a consolidated unaudited report to the Zagreb bourse.
The increase in normalised operating profit before depreciation and amortisation (EBITDA) was achieved despite a 3.2% increase in prices of raw materials, packaging and energy, it added.
In 2023, the Podravka group recorded a sales revenue of 713.8 million euro, up 7.0%, on the year.
The revenue of its food segment increased 6.0% to 553.6 million euro, while the pharmaceuticals segment generated a revenue of 160.2 million euro, up 10.5% compared to 2022.
In 2024, the Podravka group expected capital expenditures of almost 100 million euro.
Shares of the parent company of the group, Podravka d.d., traded 1.85% lower at 159 euro by 1334 local time on Wednesday on the Zagreb bourse.
($ = 0.925 euro)